Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlaytech Regulatory News (PTEC)

Share Price Information for Playtech (PTEC)

Share Price is delayed by 15 minutes
Get Live Data
345.20    -3.00 (-0.86%)
Bid:
342.40
Ask:
343.60
Spread: 1.20 (0.35%)
Market Cap: £959.13m
PTEC Live PriceLast checked at - London Stock Exchange

Intraday Playtech Share Chart

Response to statement by Evolution AB

21 Oct 2025 13:08

RNS Number : 2512E
Playtech PLC
21 October 2025
 

21 October 2025

 

Playtech plc

 

("Playtech" or the "Company")

 

Response to statement by Evolution AB

Playtech plc (LSE: PTEC) ("Playtech" or the "Company") notes the statement made today by Evolution AB ("Evolution"). The suggestion that its subsidiary, Playtech Software Limited ("PTS"), engaged in a smear campaign is wholly untrue and is designed to distract from serious questions about Evolution's business practices.

PTS commissioned an independent business intelligence firm to investigate credible and repeated concerns raised by operators, suppliers and regulators about Evolution's activities in prohibited and sanctioned markets, and its supply to unlicensed operators in regulated markets. The investigation was undertaken lawfully to better understand and verify concerns of significant regulatory and commercial importance. 

The report published, as a result of the investigation, clearly evidences that Evolution's business practices undermine lawful and compliant gambling operations. Such conduct damages trust in the credibility of the entire industry and also ultimately impacts government tax collection.

Playtech stands by the decision to commission the report. Evolution continues to seek to avoid legitimate scrutiny rather than address longstanding questions about its conduct, including its decision to supply operators in illegal markets and to support unlicensed operators in regulated markets.

Playtech welcomes court examination of the report and its findings. Playtech is confident that these proceedings will confirm the credibility and legitimacy of the investigation and the importance of the issues it seeks to address.

- ENDS -

 

For further information please contact:

 

Playtech plc

+44 (0) 20 3805 4822

Rohan Chitale, Director of Investor Relations

Headland (PR adviser to Playtech)

+44 (0) 20 3805 4822

Lucy Legh, Jack Gault

 

About Playtech 

Founded in 1999 and with a listing on the Main Market of the London Stock Exchange, Playtech is a technology leader in the gambling industry with over 7,400 employees across 20 countries.

Playtech is the gambling industry's leading technology company delivering business intelligence driven gambling software, services, content and platform technology across the industry's most popular product verticals, including, casino, live casino, sports betting, bingo and poker. It is the pioneer of omni-channel gambling technology through its integrated platform technology, Playtech ONE. Playtech ONE delivers data driven marketing expertise, single wallet functionality, CRM and responsible gambling solutions across one single platform across product verticals and across retail and online.

Playtech partners with and invests in the leading brands in regulated and newly regulated markets to deliver its data-driven gambling technology across the online and retail value chain. Playtech provides its technology on a B2B basis to the industry's leading online and retail operators, land-based casino groups and government sponsored entities such as lotteries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPEAAEFAEXSFFA
Date   Source Headline
29th May 20264:00 pmRNSDirector/PDMR Notification
20th May 20264:45 pmRNSNotification and public disclosure of transactions
20th May 20263:00 pmRNSResults of Annual General Meeting
20th May 20267:01 amRNSDirectorate Change
20th May 20267:00 amRNSAGM Trading Update
15th May 20261:00 pmRNSNotification and public disclosure of transactions
30th Apr 20263:00 pmRNSHolding(s) in Company
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20263:00 pmRNSPublication of the 2025 Annual Report & AGM Notice
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:03 pmRNSHolding(s) in Company
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 202611:56 amRNSResponse to statement by Evolution AB
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSCommencement of Share Buyback Programme
26th Mar 20267:00 amRNSFinal Results
6th Mar 20263:14 pmRNSHolding(s) in Company
5th Feb 20267:00 amRNSFY25 Trading Update
15th Jan 20267:00 amRNSAppointment of Joint Corporate Broker
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20259:10 amRNSTransaction in Own Shares
30th Dec 20259:10 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20254:57 pmRNSHolding(s) in Company
23rd Dec 20254:57 pmRNSHolding(s) in Company
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 202512:00 pmRNSDirector Declaration
18th Dec 202512:00 pmRNSDirector Declaration
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20256:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.